MATCH-D Medication Appropriateness Tool for Comorbid Health conditions during Dementia

WACHA
  • Home page
  • Early Stage Dementia
  • Mid Stage Dementia
  • Late Stage Dementia
  • All Stages
    • Principles of medication use
    • Treatment Goals
    • Medication reviews
    • Preventative medications
    • Symptom Management
    • Medications to modify dementia progression
    • Psycho-active medications
  • About
  • Research
  • Downloads
You are here: Home / Treatment Goals

Treatment Goals

Expert consensus is that these practices are recommended in the care of people with dementia

Early Stage Dementia

An important treatment goal for people living with dementia is to simplify the medication regimen.

Health professionals and the person living with dementia should discuss and document:

  • treatment goals
  • likely prognosis
  • writing an advance care directive to indicate their wishes for treatment in specific future scenarios
  • using a dose administration aid to support medication use

Health professionals and the carer or family of the person living with dementia should discuss and document:

  • treatment goals
  • likely prognosis
  • document wishes for treatment in specific future scenarios

Mid Stage Dementia

An important treatment goal for people living with dementia is to simplify the medication regimen.

Health professionals and the person living with dementia should discuss and document:

  • treatment goals
  • likely prognosis
  • writing an advance care directive to indicate their wishes for treatment in specific future scenarios
  • using a dose administration aid to support medication use

Health professionals and the carer or family of the person living with dementia should discuss and document:

  • treatment goals
  • likely prognosis
  • document wishes for treatment in specific future scenarios

Late Stage Dementia

An important treatment goal for people living with dementia is to simplify the medication regimen.

Health professionals and the person living with dementia should discuss and document:

  • likely prognosis
  • writing an advance care directive to indicate their wishes for treatment in specific future scenarios

Health professionals and the carer or family of the person living with dementia should discuss and document:

  • treatment goals
  • likely prognosis
  • document wishes for treatment in specific future scenarios


Expert consensus is that these practices are NOT recommended in the care of people with dementia

Early Stage Dementia

These treatment goals are important for people living with dementia:

  • the wishes and needs of family and carers should take priority over those of the person living with dementia
  • it is acceptable to conceal medications in food or drink if the person with dementia refuses them

Mid Stage Dementia

These treatment goals are important for people living with dementia:

  • the wishes and needs of family and carers should take priority over those of the person living with dementia
  • it is acceptable to conceal medications in food or drink if the person with dementia refuses them

DEFINITIONS

Dementia

A clinical syndrome characterized by a chronic progressive decline in neurocognitive function, specifically affecting memory, cognition, language, behaviour, emotional control, and social functioning beyond the expected effects of physiological aging and not attributable to an intercurrent illness.

The specific signs and symptoms of dementia and the rate of progression vary accordingly to the aetiology and individual. One or more aetiology may be present at the same time; the most common forms of dementia are Alzheimer’s, vascular, Lewy body, and fronto-temporal dementia.

Symptom relief

Symptom relief is defined as medication prescribed to control active disease, maintain quality of life, and relieve discomfort/distress from comorbidities. It is based on current, active symptoms rather than historical or documented symptoms.

Preventative medication

Preventative medication is defined as medication to prevent a future serious event or delay the progression of a comorbidity.

Early Stage Dementia

Mild cognitive impairment with a preserved ability to self-care and undertake activities of daily living.

Mid Stage Dementia

Moderate cognitive impairment with physical function often preserved. People with mid-stage dementia may be living with support in the community or a low care residential aged care setting.

Late Stage Dementia

Severe cognitive impairment and declining function (inability to recognise loved ones, unable to ambulate independently, incontinence of urine or faeces).

Downloads

MATCH-D Criteria

  • MATCH-D in black and white – five pages – A4
  • MATCH-D in colour – five pages – A4
  • MATCH-D as a booklet colour – twelve page – A5

Checklists – Health professional use

PDF – Early stage, Mid stage, Late stage

DOCX – Early stage, Mid stage, Late stage

Why do we need the MATCH-D criteria?

Most people living with dementia have at least one other health condition. They often use medications to manage their other health conditions, but we don’t have much information to guide us on whether this is appropriate. Information to help us optimise medication use for older adults generally are helpful, but people living with dementia have specific needs as they are living with a progressive life-limiting condition.

About MATCH-D

The MATCH-D statements are in the broad themes of preventative medication, symptom management, disease progression, psycho-active medication, treatment goals, principles of medication use, side effects, and medication reviews.

Research Team

The MATCH-D criteria was developed by an interprofessional team of Australian researchers. Dr Amy Theresa Page, Dr Kathleen Potter, Professor Rhonda Clifford and Associate Professor Christopher Etherton-Beer at the University of Western Australia and Professor Andrew McLachlan at the University of Sydney.

Research Centre

WA Centre for Health and Ageing, University of Western Australia Centre for Optimisation of Medicines, University of Western Australia

Published Research

The development of the MATCH-D is published research is available in the Internal Medicine Journal.

The enablers and barriers are published in the BMJ Open.

 

The systematic review that informed the MATCH-D criteria and the protocol are also published.

 

The publications are Open Access, meaning they are available free of charge.

Download files

MATCH-D Criteria

  • MATCH-D in black and white – five pages – A4
  • MATCH-D in colour – five pages – A4
  • MATCH-D as a booklet colour – twelve page – A5

Checklists – Health professional use

PDF – Early stage, Mid stage, Late stage

DOCX – Early stage, Mid stage, Late stage

Page A, Potter K, Clifford R, McLachlan AJ, Etherton-Beer C. Medication Appropriateness Tool for Comorbid Health conditions in Dementia (MATCH-D): Consensus recommendations from a multidisciplinary expert panel. Internal Medicine Journal. 2016 In Press